Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Test ocular hypotensive efficacy and systemic safety of netarsudil 0.01%, 0.02%, 0.04% relative to placebo in subjects with open‐angle glaucoma or ocular hypertension in Japan
Epistemonikos ID: 3aca0f5609b35fff98d5ed405ae03628022bf725
First added on: May 22, 2024